Carl Turesson
81 – 90 of 161
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
EQ-5D utility, response and drug survival in rheumatoid arthritis patients on biologic monotherapy : A prospective observational study of patients registered in the south Swedish SSATG registry
- Contribution to journal › Article
-
Mark
Large vessel involvement in biopsy-proven giant cell arteritis : incidence, distribution, and predictors
- Contribution to journal › Article
-
Mark
Rate of comorbidities in giant cell arteritis : A population-based study
- Contribution to journal › Article
-
Mark
Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the “pan-European registry collaboration for abatacept (PANABA)
- Contribution to journal › Article
-
Mark
Multiplex cytokine analyses in patients with rheumatoid arthritis require use of agents blocking heterophilic antibody activity
- Contribution to journal › Article
-
Mark
Severe extraarticular manifestations in a community based cohort of patients with rheumatoid arthritis : Risk factors and incidence in relation to treatment with tumor necrosis factor inhibitors
- Contribution to journal › Article
-
Mark
Cigarette smoking and the risk of primary Sjögren's syndrome : A nested case control study
- Contribution to journal › Article
- 2016
-
Mark
Mortality in ankylosing spondylitis: results from a nationwide population-based study.
- Contribution to journal › Article
-
Mark
A multicentre, randomised, controlled, open-label pilot study on the feasibility of discontinuation of adalimumab in established patients with rheumatoid arthritis in stable clinical remission.
- Contribution to journal › Article
-
Mark
Rheumatoid Arthritis Patients after Initiation of a New Biologic Agent : Trajectories of Disease Activity in a Large Multinational Cohort Study
- Contribution to journal › Article
